These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10993972)

  • 1. Renal Doppler sonographic and histologic findings in post-transplant primary cytomegalovirus disease.
    Salgado OJ; Henríquez C; Rosales B; Martín MG; García R; Rodríguez-Iturbe B
    J Clin Ultrasound; 2000 Oct; 28(8):430-4. PubMed ID: 10993972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CMV infections after two doses of daclizumab versus thymoglobulin in renal transplant patients receiving mycophenolate mofetil, steroids and delayed cyclosporine A.
    Abou-Ayache R; Büchler M; Lepogamp P; Westeel PF; Le Meur Y; Etienne I; Lobbedez T; Toupance O; Caillard S; Goujon JM; Bergougnoux L; Touchard G
    Nephrol Dial Transplant; 2008 Jun; 23(6):2024-32. PubMed ID: 18199693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of prophylactic oral ganciclovir and valacyclovir in high-risk kidney transplant recipients.
    Yango A; Morrissey P; Zanabli A; Beaulieu J; Shemin D; Dworkin L; Monaco A; Gohh R
    Nephrol Dial Transplant; 2003 Apr; 18(4):809-13. PubMed ID: 12637653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.
    Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD
    Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus glomerulitis in a renal allograft.
    Cathro HP; Schmitt TM
    Am J Kidney Dis; 2008 Jul; 52(1):188-92. PubMed ID: 18468750
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytomegalovirus infection after kidney transplantation and long-term graft loss.
    López-Oliva MO; Flores J; Madero R; Escuin F; Santana MJ; Bellón T; Selgas R; Jiménez C
    Nefrologia; 2017; 37(5):515-525. PubMed ID: 28946964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
    McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
    Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of breakthrough infection among cytomegalovirus donor-positive/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis.
    Stevens DR; Sawinski D; Blumberg E; Galanakis N; Bloom RD; Trofe-Clark J
    Transpl Infect Dis; 2015 Apr; 17(2):163-73. PubMed ID: 25661673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative randomised study of valacyclovir vs. oral ganciclovir for cytomegalovirus prophylaxis in renal transplant recipients.
    Pavlopoulou ID; Syriopoulou VP; Chelioti H; Daikos GL; Stamatiades D; Kostakis A; Boletis JN
    Clin Microbiol Infect; 2005 Sep; 11(9):736-43. PubMed ID: 16104989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing cytomegalovirus prophylaxis in renal transplantation: single center experience.
    Varga M; Remport A; Hídvégi M; Péter A; Kóbori L; Telkes G; Fazakas J; Gerlei Z; Sárváry E; Sulyok B; Járay J
    Transpl Infect Dis; 2005 Jun; 7(2):63-7. PubMed ID: 16150092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Resistant cytomegalovirus infection in related donor kidney allograft recipients].
    Goryainov VA; Kaabak MM; Babenko NN; Platova EN; Aganesov AG; Morozova MM; Panin VV
    Ter Arkh; 2016; 88(6):73-76. PubMed ID: 27296265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of invasive cytomegalovirus disease in solid organ transplant patients with ganciclovir.
    Dunn DL; Mayoral JL; Gillingham KJ; Loeffler CM; Brayman KL; Kramer MA; Erice A; Balfour HH; Fletcher CV; Bolman RM
    Transplantation; 1991 Jan; 51(1):98-106. PubMed ID: 1846255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-emptive therapy of CMVpp65 antigen positive renal transplant recipients with oral ganciclovir: a randomized, comparative study.
    Sagedal S; Nordal KP; Hartmann A; Midtvedt K; Foss A; Asberg A; Degré M; Fauchald P; Rollag H
    Nephrol Dial Transplant; 2003 Sep; 18(9):1899-908. PubMed ID: 12937241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacoepidemiology of cytomegalovirus prophylaxis in a large retrospective cohort of kidney transplant recipients with Medicare Part D coverage.
    Santos CA; Brennan DC; Saeed MJ; Fraser VJ; Olsen MA
    Clin Transplant; 2016 Apr; 30(4):435-44. PubMed ID: 26841129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case report of CMV hepatitis and nephropathy after living related renal transplantation].
    Tanaka S; Fujioka M; Sasaki S
    Nihon Geka Gakkai Zasshi; 1993 Dec; 94(12):1305-8. PubMed ID: 8272070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients.
    Flechner SM; Avery RK; Fisher R; Mastroianni BA; Papajcik DA; O'Malley KJ; Goormastic M; Goldfarb DA; Modlin CS; Novick AC
    Transplantation; 1998 Dec; 66(12):1682-8. PubMed ID: 9884259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leflunomide as a rescue treatment in ganciclovir-resistant cytomegalovirus infection in a seronegative renal transplant recipient--a case report.
    Ciszek M; Mucha K; Foroncewicz B; Chmura A; Pączek L
    Ann Transplant; 2014 Jan; 19():60-3. PubMed ID: 24481271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe cytomegalovirus ureteritis in a renal allograft recipient with negative CMV monitoring.
    Vaessen C; Kamar N; Mehrenberger M; Mazerolles C; Mengelle C; Rischmann P; Rostaing L; Malavaud B
    Nephrol Dial Transplant; 2005 Jan; 20(1):227-30. PubMed ID: 15632357
    [No Abstract]   [Full Text] [Related]  

  • 19. The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival.
    Smedbråten YV; Sagedal S; Leivestad T; Mjøen G; Osnes K; Rollag H; Reisaeter AV; Foss A; Os I; Hartmann A
    Clin Transplant; 2014 Jan; 28(1):120-6. PubMed ID: 24351078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment with foscarnet for ganciclovir-resistant cytomegalovirus infection in a kidney transplant recipient: A case report.
    Iwami D; Ogawa Y; Fujita H; Morita K; Sasaki H; Oishi Y; Higuchi H; Hatanaka K; Shinohara N
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():63-6. PubMed ID: 26970406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.